| Rituximab-induced subacute interstitial pneumonitis: A case report and review of literature. | |
| | |
MedLine Citation:
|
PMID: 21119272 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Rituximab is a chimeric anti-CD20 monoclonal antibody used to treat CD20+ non-Hodgkin's lymphoma (NHL). Some pulmonary adverse reactions such as cough, rhinitis, bronchospasm and dyspnea are relatively common. Severe respiratory conditions like cryptogenic organizing pneumonia, interstitial pneumonitis have rarely been reported. We present a case of interstitial pneumonitis in a patient who was treated with R-CHOP for extranodal NHL. He responded to the steroids. |
| | |
Authors:
|
Murali Subramanian; R Manjunath; Nalini Kilara; K N Mohan Rao |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of cancer research and therapeutics Volume: 6 ISSN: 1998-4138 ISO Abbreviation: J Cancer Res Ther Publication Date: 2010 Jul-Sep |
Date Detail:
|
Created Date: 2010-12-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101249598 Medline TA: J Cancer Res Ther Country: India |
Other Details:
|
Languages: eng Pagination: 344-6 Citation Subset: IM |
Affiliation:
|
Department of Medical Oncology, M. S. Ramaiah Medical College, Bangalore - 560 054, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Primary Hodgkin lymphoma of the ileum.
Next Document: Primary right atrial sarcoma.